# Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants

> **NCT01456117** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 61 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Pioglitazone
- **DRUG:** Pioglitazone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01456117
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2012-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01456117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01456117, "Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01456117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*